Short-Read NGS of a Long-Range CYP21A2 Amplicon as an Improved Alternative to Sanger Sequencing for Congenital Adrenal Hyperplasia Genetic Testing
International Journal of Molecular Sciences · 02.08.2026 · 27 (15) · 6938
DOI: 10.3390/ijms27156938 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2026. Verfasst von Zoia Antysheva und 24 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Center for Advanced Studies, Kulakova Street, 20, Moscow 123592, Russia. Hauptthemen laut MEDLINE: Steroid 21-Hydroxylase, Adrenal Hyperplasia, Congenital, High-Throughput Nucleotide Sequencing, Genetic Testing. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The standard-of-car and genetic testing for 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) is Sanger sequencing of a long-range CYP21A2 amplicon combined with multiplex ligation-dependent probe amplification (MLPA). Many Sanger sequencing protocols capture only selected regions of CYP21A2 and require several sequencing reactions. This retrospective study explores the potential of short-read next-generation sequencing (SRS) to replace Sanger sequencing in CAH genetic testing. A total of 216 participants, including CAH patients, their parents and individuals with no family history of CAH, were included. We assessed the performance of standard SRS analysis and improved upon it with developed computational software AmpliconPipe, which includes copy number calling and caller harmonization for precise variant detection. With these procedures, SRS of the CYP21A2 long-range amplicon achieved 100% sensitivity (CI 95% [94.9, 100]) and 100% specificity (CI 95% [97.4, 100]) for CAH diagnosis, and 100% sensitivity (CI 95% [94.9, 100]) with 98.6% specificity (CI 95% [95.0, 99.6]) for CAH-carrier diagnosis, with better gene coverage outperforming the standard-of-care method, discovering novel variants, and detecting CYP21A2 copy number alterations with high sensitivity. These findings establish SRS as a practical, accurate, and immediately implementable alternative to Sanger sequencing for CAH genetic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Moscow Center for Advanced Studies, Kulakova Street, 20, Moscow 123592, Russia.
- Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya Street, Moscow 125315, Russia.
- Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 1, Moscow 111123, Russia.
- Russian Children's Clinical Hospital, Leninsky Prospekt, 117, Bldg. 1, Moscow 119571, Russia.
- Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biolo…
- Faculty of Medicine, Lomonosov Moscow State University, Moscow 119991, Russia.
ORCID-Profile: Zoia Antysheva, Viktor Bogdanov, Victoria Shchekina, Ekaterina Petriaikina, Aleksey Ivashechkin, Yulia Katcaran, Vladimir Yudin, Sergey Yudin, Dmitry Svetlichnyy, Mary Woroncow, Pavel Volchkov
Förderung
- The Ministry of Education and Science of the Russian Federation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Antysheva, Z., Bogdanov, V., Rutkovskaya, E., Stepanova, A., Esibov, A., Krupinova, J., Shchekina, V., Avsievich, E., Frolova, T., Bazarova, E., Demina, E., Sharibzhanova, E., Bodunova, N., Petryaykina, E., Petriaikina, E., Ivashechkin, A., Katcaran, Y., Bukhanova, A., Yudin, V., …, & Volchkov, P. (2026). Short-Read NGS of a Long-Range CYP21A2 Amplicon as an Improved Alternative to Sanger Sequencing for Congenital Adrenal Hyperplasia Genetic Testing. International Journal of Molecular Sciences, 27(15), 6938. https://doi.org/10.3390/ijms27156938
Vancouver
Antysheva Z, Bogdanov V, Rutkovskaya E, Stepanova A, Esibov A, Krupinova J, et al. Short-Read NGS of a Long-Range CYP21A2 Amplicon as an Improved Alternative to Sanger Sequencing for Congenital Adrenal Hyperplasia Genetic Testing. International Journal of Molecular Sciences. 2026;27(15):6938. doi:10.3390/ijms27156938
BibTeX
@article{Antysheva2026,
author = {Antysheva, Zoia and Bogdanov, Viktor and Rutkovskaya, Ekaterina and Stepanova, Anna and Esibov, Anton and Krupinova, Julia and Shchekina, Victoria and Avsievich, Ekaterina and Frolova, Tatyana and Bazarova, Erzhena and Demina, Elena and Sharibzhanova, Evgenia and Bodunova, Natalia and Petryaykina, Elena and Petriaikina, Ekaterina and Ivashechkin, Aleksey and Katcaran, Yulia and Bukhanova, Anastasia and Yudin, Vladimir and Keskinov, Anton and Yudin, Sergey and Svetlichnyy, Dmitry and Woroncow, Mary and Skvortsova, Veronika and Volchkov, Pavel},
title = {Short-Read NGS of a Long-Range CYP21A2 Amplicon as an Improved Alternative to Sanger Sequencing for Congenital Adrenal Hyperplasia Genetic Testing},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6938},
doi = {10.3390/ijms27156938}
}
EUVIMED